Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.

Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease–human metapneumovirus (hMPV virus) and parainfluenza virus.

Track the development of Moderna’s mRNA medicines. From preclinical development to commercial phase.

Nov 20, 2025 · Innovation Incubator New venture labs Terms of Use Site Map Privacy Policy Contact Moderna © 2025 Moderna, Inc.

Our Mindsets Alongside our Values, our Mindsets allow us to overcome challenges together. We are working to build the best possible version of Moderna 20 years from now. These Mindsets are tools …

Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.

Resources for journalists and media members. The latest press releases by Moderna.

In addition to mRNA vaccines, Moderna is working on other applications of potential mRNA therapeutics that could help people with cancer, metabolic diseases and more.

Find contact information, important phone numbers and addresses to Moderna head.

Learn more about Spikevax® (COVID-19 Vaccine, mRNA) 2025-2026 Formula, Moderna's updated COVID-19 vaccine for individuals aged 12+. For US healthcare providers.